Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73,819,979
-
Total 13F shares
-
9,311,019
-
Share change
-
-1,318,220
-
Total reported value
-
$298,677,225
-
Put/Call ratio
-
0.22%
-
Price per share
-
$32.07
-
Number of holders
-
79
-
Value change
-
-$48,362,964
-
Number of buys
-
37
-
Number of sells
-
29
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q4 2020
As of 31 Dec 2020,
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,311,019 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, BlackRock Inc., VR Adviser, LLC, VANGUARD GROUP INC, PARSONS CAPITAL MANAGEMENT INC/RI, STATE STREET CORP, Point72 Asset Management, L.P., Invesco Ltd., and FRANKLIN RESOURCES INC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.